20 likes | 32 Views
Amyotrophic lateral sclerosis treatment market size was valued at USD 537.2 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2029. Amyotrophic sidelong sclerosis (ALS) is a neurodegenerative problem. It is the most normal sort of engine neuron infection (MND). Amyotrophic parallel sclerosis is a gathering of interesting neurological problems that principally include nerve cells liable for controlling willful muscle development. Amyotrophic parallel sclerosis is otherwise called Lou Gehrig's illness.
E N D